Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / SDC1

SDC1

Basics

Aliases:
This biomarker is also known as:
  • CD138 antigen,
  • syndecan 1,
  • heparan sulfate proteoglycan fibroblast growth factor receptor,
  • syndecan,
  • CD138,
  • syndecan proteoglycan 1,
  • P18827,
  • syndecan-1,
  • SDC,

View in BioMuta

Description…

SDC1 is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The SDC1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins.

Attributes

QA State: Curated
Type: Protein
Short Name:
HGNC Name: SDC1

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Ovary

Attributes

Phase: Two
QA State: Under Review

Overview

SDC1 was shown to localize to vascular-like structures in ovarian cancer but not in normal ovaries.

Performance Comment

SDC1 was one of 13 genes out of 50 selected for further validation in PMID:21617380.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.

Announcement